Drugs / Cholesterol
Cholesterol
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04359823 | Aug 2020 → Apr 2021 | disseminated superficial actinic porokeratosis | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00272844 | Jan 1998 → Jun 2011 | Smith-Lemli-Opitz syndrome | Boston Children's Hospital | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01773278 | Dec 2008 → Dec 2025 | Smith-Lemli-Opitz syndrome, cone-rod dystrophy, hearing loss disorder | University of Colorado, Denver | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07689435 | Jul 2026 → Jun 2027 expected | autosomal recessive congenital ichthyosis | Institute of Dermatology, Thailand | Not yet recruiting | No outcome recorded |
| — | NCT07503197 | Apr → Dec 2026 expected | atopic eczema | Institute of Dermatology, Thailand | Enrolling by invitation | No outcome recorded |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cholesterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07503197 ↗ |
| Known as | Cholest-5-en-3-ol (3.beta.)- | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Cholesterinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Cholesterol component of alf | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Cholesterol component of alf43 | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Cholesterol component of alfq | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Cholesterol component of army liposome formulation | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Dythol | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Lidinit | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Lidinite | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | NSC-8798 | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Known as | Provitamin-d | ChEMBL registry synonym — accepted as the source's own label CHEMBL112570 ↗ |
| Action | Restore | “with the aim of restoring barrier lipid structure” NCT07689435 ↗ |
| Modality | Small molecule | — CHEMBL112570 ↗ |
| Route | Topical | “topical lovastatin 2% plus cholesterol 2% cream (lovastatin-cholesterol)” PMID 36947042 ↗ May 2023 |